References
Bordier, P., Garrigue, S., Barold, S. S., Bressolles, N., Lanusse, S.,
& Clementy, J. (2003). Significance of syncope in patients with
alzheimer’s disease treated with cholinesterase
inhibitors. Europace : European Pacing, Arrhythmias, and Cardiac
Electrophysiology : Journal of the Working Groups on Cardiac Pacing,
Arrhythmias, and Cardiac Cellular Electrophysiology of the European
Society of Cardiology, 5 (4), 429-431. doi:10.1016/s1099-5129(03)00080-1
[doi]
Bordier, P., Garrigue, S., Lanusse, S., Margaine, J., Robert, F.,
Gencel, L., & Lafitte, A. (2006). Cardiovascular effects and risk of
syncope related to donepezil in patients with alzheimer’s
disease. CNS Drugs, 20 (5), 411-417. doi:2055 [pii]
Chan, A., Isbister, G. K., Kirkpatrick, C. M., & Dufful, S. B. (2007).
Drug-induced QT prolongation and torsades de pointes: Evaluation of a QT
nomogram. QJM : Monthly Journal of the Association of
Physicians, 100 (10), 609-615. doi:hcm072 [pii]
Courtney, C., Farrell, D., Gray, R., Hills, R., Lynch, L., Sellwood, E.,
. . . AD2000 Collaborative Group. (2004). Long-term donepezil treatment
in 565 patients with alzheimer’s disease (AD2000): Randomised
double-blind trial. Lancet (London, England), 363 (9427),
2105-2115. doi:10.1016/S0140-6736(04)16499-4 [doi]
Curtis, M. J., Alexander, S., Cirino, G., Docherty, J. R., George, C.
H., Giembycz, M. A., . . . Ahluwalia, A. (2018). Experimental design and
analysis and their reporting II: Updated and simplified guidance for
authors and peer reviewers. British Journal of
Pharmacology, 175 (7), 987-993. doi:10.1111/bph.14153
Hernandez, R. K., Farwell, W., Cantor, M. D., & Lawler, E. V. (2009).
Cholinesterase inhibitors and incidence of bradycardia in patients with
dementia in the veterans affairs new england healthcare
system.Journal of the American Geriatrics Society, 57 (11),
1997-2003. doi:10.1111/j.1532-5415.2009.02488.x [doi]
Igeta, H., Suzuki, Y., Tajiri, M., & Someya, T. (2014). Cardiovascular
pharmacodynamics of donepezil hydrochloride on the PR and QT intervals
in patients with dementia. Human Psychopharmacology, 29 (3),
292-294. doi:10.1002/hup.2398 [doi]
Isik, A. T., Bozoglu, E., Yay, A., Soysal, P., & Ateskan, U. (2012).
Which cholinesterase inhibitor is the safest for the heart in elderly
patients with alzheimer’s disease? American Journal of Alzheimer’s
Disease and Other Dementias, 27 (3), 171-174.
doi:10.1177/1533317512442999 [doi]
Kerr, S. R., Pearce, M. S., Brayne, C., Davis, R. J., & Kenny, R. A.
(2006). Carotid sinus hypersensitivity in asymptomatic older persons:
Implications for diagnosis of syncope and falls. Archives of
Internal Medicine, 166 (5), 515-520. doi:166/5/515 [pii]
Kumar, N. P., Thomas, A., Mudd, P., Morris, R. O., & Masud, T. (2003).
The usefulness of carotid sinus massage in different patient
groups. Age and Ageing, 32 (6), 666-669. doi:10.1093/ageing/afg114
[doi]
Li, K., Cheng, N., & Li, X. T. (2017). Inhibitory effects of
cholinesterase inhibitor donepezil on the Kv1.5 potassium
channel. Scientific Reports, 7 , 41509. doi:10.1038/srep41509
[doi]
Malik, B. H., Hamid, P., Khan, S., Gupta, D., & Islam, M. (2019).
Correlation between donepezil and QTc prolongation and torsades de
pointes: A very rare phenomenon. Cureus, 11 (12), e6451.
doi:10.7759/cureus.6451 [doi]
Malik, M., & Batchvarov, V. N. (2000). Measurement, interpretation and
clinical potential of QT dispersion. Journal of the American
College of Cardiology, 36 (6), 1749-1766. doi:S0735-1097(00)00962-1
[pii]
Mandal, A. K. J., Khan, U. F., & Missouris, C. G. (2019). Ventricular
tachycardia in a patient with sigmoid volvulus on treatment with
donepezil. Clinical Toxicology (Philadelphia, Pa.), 57 (12),
1157-1159. doi:10.1080/15563650.2019.1588288 [doi]
Park-Wyllie, L. Y., Mamdani, M. M., Li, P., Gill, S. S., Laupacis, A.,
& Juurlink, D. N. (2009). Cholinesterase inhibitors and hospitalization
for bradycardia: A population-based study. PLoS Medicine, 6 (9),
e1000157. doi:10.1371/journal.pmed.1000157 [doi]
Rabkin, S. W. (2015). Impact of age and sex on QT prolongation in
patients receiving psychotropics. Canadian Journal of
Psychiatry.Revue Canadienne De Psychiatrie, 60 (5), 206-214.
doi:cjp-2015-vol60-may-206-214 [pii]
Rabkin, S. W., Cheng, X. J., & Thompson, D. J. (2016). Detailed
analysis of the impact of age on the QT interval. Journal of
Geriatric Cardiology : JGC, 13 (9), 740-748. doi:jgc-13-09-740 [pii]
Roden, D. M. (2008). Keep the QT interval: It is a reliable predictor of
ventricular arrhythmias. Heart Rhythm, 5 (8), 1213-1215.
doi:10.1016/j.hrthm.2008.05.008 [doi]
Sato, K., Urbano, R., Yu, C., Yamasaki, F., Sato, T., Jordan, J., . . .
Diedrich, A. (2010). The effect of donepezil treatment on cardiovascular
mortality. Clinical Pharmacology and Therapeutics, 88 (3),
335-338. doi:10.1038/clpt.2010.98 [doi]
Takaya, T., Okamoto, M., Yodoi, K., Hata, K., Kijima, Y., Nakajima, H.,
. . . Kawashima, S. (2009). Torsades de pointes with QT prolongation
related to donepezil use. Journal of Cardiology, 54 (3), 507-511.
doi:10.1016/j.jjcc.2009.03.011 [doi]
Tan, M. P., Newton, J. L., Reeve, P., Murray, A., Chadwick, T. J., &
Parry, S. W. (2009). Results of carotid sinus massage in a tertiary
referral unit–is carotid sinus syndrome still relevant? Age and
Ageing, 38 (6), 680-686. doi:10.1093/ageing/afp160 [doi]
Tsutsui, J. M., Falcao, S. N., Dourado, P. M., Lima, M. F., Alves, A.
A., Guerra, V. C., . . . Mathias, W. (2007). Gender differences in
chronotropic and hemodynamic responses during dobutamine-atropine stress
echocardiography. Echocardiography (Mount Kisco, N.Y.), 24 (8),
843-850. doi:ECHO487 [pii]
United States Food and Drug Administration. (2012). Aricept (donepezil
hydrochloride). Retrieved
from https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020690s035,021720s008,022568s005lbl.pdf
Wang, D., Wu, Y., Wang, A., Chen, Y., Zhang, T., & Hu, N. (2018).
Electrocardiogram changes of donepezil administration in elderly
patients with ischemic heart disease. Cardiology Research and
Practice, 2018 , 9141320. doi:10.1155/2018/9141320 [doi]